SREBP2 Antibody - #DF7601

>>买2送1 进行中>>
>>赠JD卡 进行中>>
(11)   (8)  
产品: SREBP2 抗体
货号: DF7601
描述: Rabbit polyclonal antibody to SREBP2
应用: WB IHC
文献验证: WB, IHC
反应: Human, Mouse, Rat
预测: Pig, Zebrafish, Bovine, Horse, Sheep, Rabbit, Dog, Chicken, Xenopus
蛋白号: Q12772
RRID: AB_2841092

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售
相关下载
MS Report
HPLC Report
MSDS
说明书
COA
实验方案
WB Handbook
IHC Protocol
IF/ICC Protocol

产品描述

来源:
Rabbit
应用:
WB 1:1000-3000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
SREBP2 Antibody detects endogenous levels of total SREBP2.
RRID:
AB_2841092
引用格式: Affinity Biosciences Cat# DF7601, RRID:AB_2841092.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

AI608257; bHLHd2; Class D basic helix-loop-helix protein 2; OTTHUMP00000028740; Processed sterol regulatory element-binding protein 2; SRBP2_HUMAN; SREBF 2; Srebf2; SREBF2 protein; SREBP 2; SREBP-2; SREBP2; SREBP2gc; sterol regulatory element binding factor 2; Sterol regulatory element binding protein 2; Sterol regulatory element binding transcription factor 2; Sterol regulatory element-binding transcription factor 2;

抗原和靶标

免疫原:

A synthesized peptide derived from human SREBP2, corresponding to a region within the internal amino acids.

基因/基因ID:
SREBF2(6721)

文献引用

1). CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease. Metabolism: clinical and experimental, 2024 (PubMed: 37952690) [IF=10.8]
2). NPY stimulates cholesterol synthesis acutely by activating the SREBP2-HMGCR pathway through the Y1 and Y5 receptors in murine hepatocytes. LIFE SCIENCES, 2020 (PubMed: 32976883) [IF=5.2]

Application: WB    Species: rat    Sample: BRL-3A hepatocytes

Fig. 3. |NPY promotes pSREBP2 expression and accelerates the processing of pSREBP2 to mSREBP2 both in vivo and in vitro.(A) Hepatic portal vein injection of NPY (100 μg/kg) significantly increased both pSREBP2 expression and mSREBP2 maturation after 1 h in rats.
3). Digeda-4 decoction and its disassembled prescriptions improve dyslipidemia and apoptosis by regulating AMPK/SIRT1 pathway on tyloxapol-induced nonalcoholic fatty liver disease in mice. Journal of Ethnopharmacology, 2023 (PubMed: 37348794) [IF=4.8]
4). Alcohol intake exacerbates experimental autoimmune prostatitis through gut microbiota driving cholesterol biosynthesis-mediated Th17 differentiation. International immunopharmacology, 2024 (PubMed: 39029231) [IF=4.8]
5). Resveratrol Improves the Progression of Osteoarthritis by Regulating the SIRT1-FoxO1 Pathway-Mediated Cholesterol Metabolism. MEDIATORS OF INFLAMMATION, 2023 (PubMed: 36643587) [IF=4.4]
6). Hypermethylation of the CTRP9 promoter region promotes Hcy induced VSMC lipid deposition and foam cell formation via negatively regulating ER stress. Scientific reports, 2023 (PubMed: 37945738) [IF=3.8]

Application: WB    Species: Human    Sample: VSMC

Figure 4. Effects of CTRP9 on the expression of ERs marker proteins and lipid homeostasis regulatory factors in VSMC. (A) CTRP9 mRNA and protein expression levels. (B) ATF6a mRNA and protein expression levels. (C) mRNA and protein expression levels of CRP78. (D) Expression levels of IRE1a mRNA and p-IRE1a protein. (E) Expression levels of PERK mRNA and p-PERK protein. (F) SREBP1c mRNA and protein expression levels. (G) SREBP2 mRNA and protein expression levels. The experiment was performed in triplicate, and the representative images are shown. *P 
7). MiR-204-5p promotes apoptosis and inhibits migration of osteosarcoma via targeting EBF2. BIOCHIMIE, 2019 (PubMed: 30529043) [IF=3.3]

Application: WB    Species: human    Sample: MG63 cells

Figure 4.| MiR-204-5p targets EBF2 .D. WB analysis of EBF2 protein levels in MG63 cells transfected with control miRNA (miR-NC), miR-204-5p, control antagomiR (anti-miR-NC) and antagomiR-204-5p (anti-miR-204-5p).

Application: IHC    Species: human    Sample: Migrated Saos-2 and MG63 cells

Figure 5. |EBF2 inhibits apoptosis and promotes migration and invasion of osteosarcoma.E. Migrated Saos-2 and MG63 cells transfected with control siRNA (si-NC) and EBF2 siRNA (si-EBF2). Lower panels are statistics of transwell results. Data were presented as means ± SD. *=P<0.05, **=P<0.01 and ***=P<0.001
8). Sleeve Gastrectomy Suppresses Hepatic De Novo Cholesterogenesis and Improves Hepatic Cholesterol Accumulation in Obese Rats with Type 2 Diabetes Mellitus. NUTRITION, 2022 (PubMed: 34952362) [IF=3.2]
9). Metformin mitigates cholesterol accumulation via the AMPK/SIRT1 pathway to protect osteoarthritis chondrocytes. Biochemical and biophysical research communications, 2022 (PubMed: 36206595) [IF=2.5]
10). The Hypolipidemic Effect of Hawthorn Leaf Flavonoids through Modulating Lipid Metabolism and Gut Microbiota in Hyperlipidemic Rats. Evidence-based complementary and alternative medicine : eCAM, 2021 (PubMed: 36425260)

Application: WB    Species: Rat    Sample:

Figure 14 The potential drug targets for antihyperlipidemia by HLF. (a) The level of CYP7A1 in the intestinal tissue; (b) the level of HMGCR in the plasma level; (c) the expression of related targets in the liver; (d) the expression of related targets in the intestine. These data are presented as the mean ± SD (n = 3).
加载更多

限制条款

产品的规格、报价、验证数据请以官网为准，官网链接：www.affbiotech.com | www.affbiotech.cn（简体中文）| www.affbiotech.jp（日本語）

产品的数据信息为Affinity所有，未经授权不得收集Affinity官网数据或资料用于商业用途，对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整，如您已订购该产品，请以订购时随货说明书为准，否则请以官网内容为准，官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时，请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.